Embla Medical Overview
- Year Founded
-
1971
- Status
-
Public
- Employees
-
4,000
- Stock Symbol
-
EMBLA
- Investments
-
24
- Share Price
-
$4.27
- (As of Tuesday Closing)
Embla Medical General Information
Description
Embla Medical hf is is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. Embla Medical operates within three business segments of the non-invasive orthopedics market; Prosthetics and Neuro Orthotics; Bracing and Supports; and Patient Care. Key revenue is generated from Prosthetics and Neuro Orthotics; segment.
Contact Information
Website
www.emblamedical.comCorporate Office
- Grjothals 1-5
- Reykjavik, 110
- Iceland
Corporate Office
- Grjothals 1-5
- Reykjavik, 110
- Iceland
Embla Medical Stock Performance
As of 29-Apr-2025, Embla Medical’s stock price is $4.27. Its current market cap is $1.82B with 426M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.27 | $4.10 | $3.68 - $5.37 | $1.82B | 426M | 55.3K | $0.17 |
Embla Medical Financials Summary
As of 31-Mar-2025, Embla Medical has a trailing 12-month revenue of $858M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 2,156,211 | 2,583,185 | 2,100,602 | 2,409,760 |
| Revenue | 857,822 | 854,889 | 785,683 | 718,650 |
| EBITDA | 172,615 | 167,818 | 140,438 | 115,962 |
| Net Income | 72,178 | 68,278 | 58,389 | 42,513 |
| Total Assets | 1,588,658 | 1,538,965 | 1,385,682 | 1,325,361 |
| Total Debt | 528,547 | 499,789 | 467,733 | 480,923 |
Embla Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Embla Medical Comparisons
Industry
Financing
Details
Embla Medical Competitors (3)
One of Embla Medical’s 3 competitors is Integra Lifesciences, a Corporation company based in Princeton, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Integra Lifesciences | Corporation | Princeton, NJ | ||||
| Globus Medical | Formerly VC-backed | Audubon, PA | ||||
| Orthofix International | Formerly PE-Backed | Lewisville, TX |
Embla Medical Patents
Embla Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200268539-A1 | Orthopedic device having a dynamic control system | Active | 31-Oct-2014 | ||
| US-11628081-B2 | Orthopedic device having a dynamic control system | Active | 31-Oct-2014 | ||
| US-20160120683-A1 | Orthopedic device having a dynamic control system | Active | 31-Oct-2014 | ||
| US-10653546-B2 | Orthopedic device having a dynamic control system | Active | 31-Oct-2014 | ||
| US-11304838-B2 | Support for articles and methods for using the same | Active | 01-Oct-2014 | A61F5/0109 |
Embla Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Embla Medical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Embla Medical Investments & Acquisitions (24)
Embla Medical’s most recent deal was a Merger/Acquisition with FIOR & GENTZ for . The deal was made on 15-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| FIOR & GENTZ | 15-Jan-2024 | Merger/Acquisition | Therapeutic Devices | ||
| Naked Prosthetics | 26-Aug-2022 | Merger/Acquisition | Therapeutic Devices | ||
| ProReva | 18-Feb-2022 | Merger/Acquisition | Therapeutic Devices | ||
| Premier Prosthetics and Orthotics | 29-Apr-2021 | Merger/Acquisition | Other Healthcare Services | ||
| Orthoway | 30-Dec-2020 | Merger/Acquisition | Therapeutic Devices |
Embla Medical ESG
Risk Overview
Risk Rating
Updated November, 28, 2024
21.88 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,109
Rank
Percentile
Healthcare
Industry
of 587
Rank
Percentile
Medical Devices
Subindustry
of 198
Rank
Percentile
Embla Medical Exits (2)
Embla Medical’s most recent exit was on 01-Jan-2007 from Restore Motion. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Restore Motion | 01-Jan-2007 | Completed |
|
||
| Gibaud | 21-Dec-2006 | Merger/Acquisition | Completed |
Embla Medical Affiliates
Subsidiaries (6)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Naked Prosthetics | Olympia, WA | 2011 | |
| APC Prosthetics | Alexandria, Australia | 1998 | |
| FIOR & GENTZ | Luneburg, Germany | 1997 | |
| College Park Industries | Warren, MI | 1988 | |
| Orthoway | Cambrai, France | 1980 |
Embla Medical FAQs
-
When was Embla Medical founded?
Embla Medical was founded in 1971.
-
Where is Embla Medical headquartered?
Embla Medical is headquartered in Reykjavik, Iceland.
-
What is the size of Embla Medical?
Embla Medical has 4,000 total employees.
-
What industry is Embla Medical in?
Embla Medical’s primary industry is Therapeutic Devices.
-
Is Embla Medical a private or public company?
Embla Medical is a Public company.
-
What is Embla Medical’s stock symbol?
The ticker symbol for Embla Medical is EMBLA.
-
What is the current stock price of Embla Medical?
As of 29-Apr-2025 the stock price of Embla Medical is $4.27.
-
What is the current market cap of Embla Medical?
The current market capitalization of Embla Medical is $1.82B.
-
What is Embla Medical’s current revenue?
The trailing twelve month revenue for Embla Medical is $858M.
-
Who are Embla Medical’s competitors?
Integra Lifesciences, Globus Medical, and Orthofix International are competitors of Embla Medical.
-
What is Embla Medical’s annual earnings per share (EPS)?
Embla Medical’s EPS for 12 months was $0.17.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
